Albert Dobi
9Patents
2h-index
17Co-inventors
44Inventor score
Filing activity: Oct 9, 2007 → Jan 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9206481B2 | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations | Chemistry; Metallurgy | 8 | Active |
| US8541169B2 | Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations | Chemistry; Metallurgy | 3 | Active |
| US10238639B2 | Azophenols as ERG oncogene inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10711311B2 | Genomic rearrangements associated with prostate cancer and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US10287587B2 | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations | Chemistry; Metallurgy | 0 | Active |
| US11492414B2 | ERG monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US11648239B2 | Azophenols as ERG oncogene inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12320812B2 | Markers for the diagnosis of biochemical recurrence in prostate cancer | Physics | 0 | Active |
| US8765916B2 | ERG monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.